aaebbeeeaca

Nivedha Elango

Disclosure: I am in full compliance with all ethics and other policies for Market Realist research analysts. I am not invested in securities that I cover on Market Realist.

More From Nivedha Elango

  • Cannabis

    A Closer Look at Arizona’s Marijuana Laws

    Arizona is one US state with strong opposition to marijuana legalization. It legalized the use of medical marijuana in 2010 after many failed initiatives.

    By Nivedha Elango
  • Cannabis

    Your Guide to Ohio Marijuana Law

    Ohio legalized the medical use of marijuana in 2016, but it’s failed in its attempts to legalize the recreational use of cannabis.

    By Nivedha Elango
  • Cannabis

    Why Alberta Is Holding Off on Vaping Products

    It looks like vaping products won’t be available in the Alberta cannabis market anytime soon. Though Canada permits their sale, the province is skeptical.

    By Nivedha Elango
  • Cannabis

    Organigram Launches Cannabis 2.0 Products

    On December 17, Organigram Holdings released its first batch of Cannabis 2.0 products to Manitoba, Ontario, Nova Scotia, Saskatchewan, and New Brunswick.

    By Nivedha Elango
  • Cannabis

    Analyst Believes Curaleaf Still Has Room to Grow

    Beacon Securities analyst Russell Stanley expects Curaleaf stock to grow 255% in the next 12 months. Stanley gave a target price of 25 Canadian dollars.

    By Nivedha Elango
  • Cannabis

    Tilray’s Latest Ratings: Analysts Are Undecided

    Tilray has frequently been in the news lately. Despite its efforts, its stock has continued to fall for the last month. It’s currently trading at $17.31.

    By Nivedha Elango
  • Cannabis

    Tilray Exports to Switzerland and 13 Other Countries

    In recent news, Tilray Inc. (TLRY) exported medical marijuana to Switzerland. The company exported medical marijuana extracts to cater to the needs of patients in Switzerland. Apart from Switzerland, TLRY exports to medical cannabis markets in 13 other countries. Tilray’s exports Tilray exported medical marijuana extracts from its GMP-certified facility to Switzerland. The company got […]

    By Nivedha Elango
  • Guides

    A Curaleaf Overview: Origins, Products, and More

    Curaleaf Holdings (CURLF) (CURA) is one of the leading vertically integrated cannabis players in the US. The company has operations in 12 states.

    By Nivedha Elango
  • Cannabis

    Trulieve Is Under Attack from Short Sellers

    In recent news, short seller Grizzly Research released a report attacking leading cannabis company Trulieve Cannabis (TRUL) (TCNNF)..

    By Nivedha Elango
  • uploads///Chart  Valuation
    Cannabis

    A Guide to Marijuana Laws in Michigan

    The launch of recreational cannabis products in Michigan was scheduled for spring 2020. The Marijuana Regulatory Agency moved the launch to December 1.

    By Nivedha Elango
  • Cannabis

    Green Thumb, Liberty Health Open New Locations

    Recently, leading cannabis companies Green Thumb Industries (GTBIF) and Liberty Health Sciences (LHSIF) launched retail stores in new locations.

    By Nivedha Elango
  • uploads///Chart  Valuation
    Cannabis

    Understanding MedMen’s Cannabis Logistics Software

    Cannabis retailer MedMen Enterprises (MMNFF) has partnered with Onfleet software to handle its multistate logistics.

    By Nivedha Elango
  • Cannabis

    How Texas Marijuana Law Has Evolved Over the Years

    Texas marijuana laws have been some of the most conservative in the US, but that’s slowly changing. Let’s take a closer look.

    By Nivedha Elango
  • uploads///Chart  Dividend
    Guides

    What the MORE Act Would Mean for the US

    Cannabis is still listed as a Schedule I drug under US federal law. The most recent bill introduced to change this situation is the MORE Act.

    By Nivedha Elango
  • Cannabis

    What Tilray’s New License Means for It

    On December 11, Tilray’s (TLRY) wholly-owned subsidiary, Tilray Portugal, received an additional Good Manufacturing Practice certification.

    By Nivedha Elango
  • Cannabis

    The SQDC Is Cashing In on Cannabis in Québec

    The SQDC (Société Québécoise du Cannabis), which got its start more than a year ago, recorded huge profits in the second quarter of fiscal 2020.

    By Nivedha Elango
  • uploads///
    Cannabis

    Why Trulieve’s CEO Says Cannabis Isn’t Dead

    Some experts and investors speculate that the cannabis bubble has burst. However, Trulieve Cannabis’s CEO believes the industry is still thriving.

    By Nivedha Elango
  • Cannabis

    US Cannabis Legalization: The Latest Updates

    Medical cannabis is legal in 33 US states, recreational cannabis is legal in 11, and 15 states have decriminalized it. These numbers might soon increase.

    By Nivedha Elango
  • Cannabis

    Does Texas Want Marijuana Legalized?

    Texas has some of the most restrictive marijuana laws in the US. Medical marijuana is permitted in some cases, and recreational marijuana is illegal.

    By Nivedha Elango
  • uploads///HD_
    Cannabis

    Aurora Eyes the US Cannabis Market

    Aurora Cannabis (ACB) (ACB.TO) is a Canadian cannabis giant, but the company’s plans to enter the US market keep getting delayed.

    By Nivedha Elango
  • Cannabis

    Cannabis: Legal Market versus Black Market

    The cannabis industry has been growing exponentially for the past few years. As the cannabis market keeps growing, the black market is growing too.

    By Nivedha Elango
  • uploads///
    Cannabis

    Aurora Cannabis Gets Product Approval in Ireland

    Aurora Cannabis recently received approval to use one of its oil products under Ireland’s Medical Cannabis Access Programme.

    By Nivedha Elango
  • Guides

    Edibles and You: The Effects of Ingesting Cannabis

    With Cannabis 2.0 rolling out, cannabis companies are working on innovative product lines to secure their shares of the new edibles market.

    By Nivedha Elango
  • Guides

    Aphria: A Company Overview and a Look at 2020

    Aphria produces and sells medical and recreational cannabis in Canada via award-winning brands. It aims to be the world’s best-performing cannabis company.

    By Nivedha Elango
  • Cannabis

    FSD Pharma Reported Q3 Earnings after Losses

    Cobourg-based cannabis operation FSD Pharma (HUGE.CN) (FSDDF) recently announced its third-quarter earnings fiscal 2019 results on November 29. The results are for the three month period ending on September 30, 2019. Since the time of the announcement, the stock has been trading in the same line. Currently, it’s trading at $4.89. FSD Pharma financial highlights […]

    By Nivedha Elango
  • Cannabis

    Khiron Life Science Q3 Earnings Update

    Toronto-based cannabis player Khiron Life Science (KHRN) announced its third-quarter fiscal 2019 earnings results on November 26. Since the time of the announcement, the stock fell by more than 7%. Currently, it’s trading at $0.90. Khiron Life Science financial highlights Khiron Life Science reported revenue of $2.8 million in the third quarter. The revenue consists of […]

    By Nivedha Elango
  • Cannabis

    Trump Administration Sets Minimum Age for Vaping

    In recent news, President Donald Trump proposed a minimum age of 21 for using e-cigarette products. Trump previously expressed his support to ban vaping. However, he changed his mind as he believes the ban will lead to a rise in the black market. As the country took a big hit due to vaping illness, this action […]

    By Nivedha Elango
  • Cannabis

    US Government Prohibits Funding for Marijuana

    In a recent update on the standoff between state and federal government, the US government cut federal grants for treatments using medical marijuana. This move by the federal government goes against the states that legalized marijuana for medical conditions without significant scientific evidence. This is especially true for the states that allow marijuana treatment for […]

    By Nivedha Elango
  • Cannabis

    Raymond James on Cannabis Sector Outlook

    After a long stretch of time, the cannabis sector had a good week as some of the companies reported profits. Many analysts see this as a positive sign for investors in the industry. Rahul Sarugaser, an analyst for Raymond James, recently pointed to the improvements in the US legal framework as well as the Ontario […]

    By Nivedha Elango
  • Cannabis

    How MedMen Is Staking Its Claim in Cannabis Retail

    Major US cannabis retailer MedMen aims to expand its brand by increasing its number of flagship retail stores and offering high-quality cannabis products.

    By Nivedha Elango
  • uploads///hanger _
    Cannabis

    Aurora Cannabis Opens Flagship Store in Edmonton

    Aurora Cannabis has announced the opening of its new flagship retail store. This new operation is located in the West Edmonton Mall in Edmonton, Alberta.

    By Nivedha Elango
  • Cannabis

    Planet 13 Stock Is Down 15% Since Its Q3 Earnings

    Planet 13 Holdings announced its third-quarter earnings results on November 25. Since the time of the announcement, the stock has fallen 15%.

    By Nivedha Elango
  • uploads///
    Guides

    A CBD Comparison: Hemp versus Marijuana

    As medical marijuana is legal in several countries, CBD has become a frequently used medicine. Two types of cannabis plants produce CBD: hemp and marijuana.

    By Nivedha Elango
  • uploads///
    Cannabis

    Canopy Growth Gets Beverage Facility License

    On November 22, Canopy Growth received a license from Health Canada for a 150,000-square-foot beverage-production facility in Smiths Falls, Ontario.

    By Nivedha Elango
  • uploads///image
    Cannabis

    Minnesota Cannabis Legalization: A Work in Progress

    Marijuana legalization is a recurring subject of discussion in the US, and the debate about marijuana’s benefits is ongoing. What’s the latest in Minnesota?

    By Nivedha Elango
  • Cannabis

    Is the Cannabis Industry Dead or Alive?

    The cannabis industry has seen massive growth in recent years, but marijuana stocks have been plummeting lately. Are these indications of a dying industry?

    By Nivedha Elango
  • uploads///
    Cannabis

    Does Canopy Growth Have Leadership Issues?

    Canopy Growth recently reported pretty dismal quarterly results. Some suggest that the company’s headwinds are the result of terrible governance.

    By Nivedha Elango
  • Cannabis

    Aurora Cannabis Hit with Securities Lawsuits

    Recently, three law firms filed lawsuits against Aurora Cannabis to investigate claims representing the buyers of Aurora Cannabis securities.

    By Nivedha Elango
  • uploads///TGT Valuation
    Cannabis

    Illegal Cannabis Market Overshadows Legal One

    Cannabis companies expect Cannabis 2.0 to improve their top lines and profitabilities. However, illegal cannabis already has a considerable market share.

    By Nivedha Elango
  • uploads///TGT ANR
    Analyst Price Target

    Scotts Miracle-Gro: Analysts’ Ratings after Q4

    Scotts Miracle-Gro released its fiscal 2019 fourth-quarter and full-year results on November 6. Its stock has fallen 3.55% since its earnings release.

    By Nivedha Elango
  • uploads///TGT Margins
    Analyst Price Target

    KushCo: 6 Analysts Say “Buy,” Price Target Shrinks

    KushCo Holdings (KSHB) recently announced its fourth-quarter and full-year financial results. The company reported impressive results, beating analyst estimates. The company’s stock is trading in the same line since the day of the earnings release. Currently, the stock is trading at $1.83 as of November 21. KushCo financial highlights KushCo analysts reported $47 million in […]

    By Nivedha Elango
  • Cannabis

    Arizona Marijuana: Five Key Takeaways

    Arizona is a conservative state when it comes to marijuana laws. The state allowed the use of medical marijuana in 2010. The proposal for allowing medical marijuana passed after years of failed propositions. Currently, recreational marijuana is illegal in the state. However, the state is preparing for a proposition to allow recreational marijuana in 2020. […]

    By Nivedha Elango
  • uploads///Roku Q reve growth
    Cannabis

    Charlotte’s Web: An Overview of a Cannabis Giant

    Charlotte’s Web Holdings, Inc. (CWEB) is a US-based vertically integrated CBD producer. The company focuses on making and distributing hemp-derived CBD products. Charlotte’s Web’s mission is to help people find peace in mind, body, and soul. Further, the company aims to meet the consumer’s demands for quality products, efficiency, and consistency. Initial development Charlotte’s Web […]

    By Nivedha Elango
  • uploads///TGT Digital
    Analyst Price Target

    HEXO Corp: Analysts’ Ratings and Price Target

    HEXO Corp (HEXO) is a Canada-based cannabis company. Recently, the company announced its fourth-quarter results for the period ending on July 31, 2019. The company’s revenue missed the estimates of the analysts. HEXO’s stock value fell by 20% from the time of the earnings release. Also, the company’s stock is currently traded at $1.79. HEXO’s […]

    By Nivedha Elango
  • uploads///TGT Traffic
    Cannabis

    Candidates Condemn Biden’s Gateway Drug Views

    Joe Biden said that using recreational marijuana might be considered a gateway drug. He received criticism from many of his fellow candidates.

    By Nivedha Elango
  • Cannabis

    Canopy Growth’s Q2 Earnings: Top Five Takeaways

    Leading cannabis producer Canopy Growth reported disappointing fiscal 2020 second-quarter earnings results on November 14.

    By Nivedha Elango
  • Analyst Price Target

    Tilray Struggles Post-Q3 as Most Analysts Say ‘Hold’

    Like many of its peers, Tilray is struggling after its fiscal 2019 third-quarter release. Though its revenue met estimates, its stock continues to slide.

    By Nivedha Elango
  • Cannabis

    Canopy Growth: An Overview of the Cannabis Giant

    Canopy Growth operates in 14 countries on five continents. The company has expanded through strategic partnerships, acquisitions, and supply agreements.

    By Nivedha Elango
  • Cannabis

    Acreage’s Q3 Missed Expectations, but It’s Optimistic

    Acreage Holdings reported its third-quarter earnings results on November 12. The company’s earnings were lower than analysts’ expectations.

    By Nivedha Elango
  • uploads///image
    Cannabis

    Tilray Tumbles following Its Q3 Earnings Report

    Tilray reported its third-quarter earnings results on November 12. It reported five times its revenue from last year’s third quarter.

    By Nivedha Elango
  • uploads///P
    Cannabis

    Aleafia Health Hits a Profit Milestone in Q3

    Aleafia Health reported its third-quarter earnings results on November 12. The cannabis producer reported a positive net profit for the first time.

    By Nivedha Elango
  • Analyst Price Target

    GW Pharmaceuticals: Analysts’ Ratings, Price Target

    GW Pharmaceuticals (GWPH) recently reported its QA3 results. Although its financials beat estimates, the company’s stock has fallen 18% since then.

    By Nivedha Elango
  • Cannabis

    Canopy Growth Sponsors Clinical Trial of CBD

    According to recent news, Canopy Growth is sponsoring a clinical trial exploring CBD’s effects on social anxiety disorder.

    By Nivedha Elango
  • uploads///image
    Cannabis

    OrganiGram’s Q4: Big 2019 Growth, Big 2020 Plans?

    OrganiGram is set to report its fiscal 2019 fourth-quarter earnings results on November 25. It will report its numbers for the quarter and the full year.

    By Nivedha Elango
  • Cannabis

    Why Cronos’s Listing in Australia Is Important

    Cronos Australia (CAU.AX) was recently listed on the Australian Stock Exchange. Its IPO recently raised 20 million Australian dollars.

    By Nivedha Elango
  • Cannabis

    Canopy Rivers Gears Up for Cannabis 2.0

    Canopy Rivers is gearing up to take advantage of the Cannabis 2.0 market, and it has a laundry list of subsidiary companies to help it do so.

    By Nivedha Elango
  • Cannabis

    Tilray: What to Expect from Its Q3 Earnings

    Global cannabis producer Tilray (TLRY) plans to announce its Q3 results on November 12. So far this month, Tilray’s stock price has risen by 2.6%.

    By Nivedha Elango
  • Cannabis

    Cresco Labs Kicks Off Its Incubator Program in Illinois

    Cresco Labs launched its incubator program in Illinois on November 6. This program is part of Cresco’s Social Equity and Educational Development initiative.

    By Nivedha Elango
  • Cannabis

    KushCo Launches New Hemp Trading Business

    KushCo is expanding its CBD footprint by launching a hemp trading business. KushCo is promoting hemp trading with farmers and a verified buyer network.

    By Nivedha Elango
  • Cannabis

    Is Michigan Rolling Out Recreational Licenses?

    Michigan is rolling out licenses for recreational cannabis businesses. The state’s Marijuana Regulatory Agency has been accepting applications since November 1, 2019.

    By Nivedha Elango
  • uploads///part
    Cannabis

    Cannabis: Why Quebec Raised the Legal Age to 21

    Quebec recently passed a bill to raise the legal age for cannabis consumption from 18 to 21. This law will become effective on January 1, 2020.

    By Nivedha Elango
  • Cannabis

    Curaleaf Buys Acres Cannabis and MACHNV LLC

    Curaleaf Holdings, Inc. (CURLF) (CURA) recently closed a deal with Acres Cannabis. Curaleaf bought Acres’ cultivation and production facilities in Amargosa Valley, Nevada. This 269,000-square-foot facility is for processing. With this deal, the company can expand its cultivation and processing operations in Nevada. Details of the deal On March 18, 2019, Curaleaf signed a deal […]

    By Nivedha Elango
  • uploads///TJX Sales
    Cannabis

    MedMen Buds: Loyalty Program Information

    MedMen (MMNFF) is a vertically integrated cannabis retailer with its footprint across the US. The company is in nine states and has 32 stores and 70 retail licenses. Recently, the company launched a loyalty program called MedMen buds. Also, the company launched its omnichannel delivery services in August. What is MedMen Buds? MedMen Buds is […]

    By Nivedha Elango
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.